CN114223908A - Mineral trace element and taurine composite product, preparation method and application - Google Patents
Mineral trace element and taurine composite product, preparation method and application Download PDFInfo
- Publication number
- CN114223908A CN114223908A CN202111614703.XA CN202111614703A CN114223908A CN 114223908 A CN114223908 A CN 114223908A CN 202111614703 A CN202111614703 A CN 202111614703A CN 114223908 A CN114223908 A CN 114223908A
- Authority
- CN
- China
- Prior art keywords
- taurine
- parts
- composite product
- stirring
- mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 112
- 229960003080 taurine Drugs 0.000 title claims abstract description 51
- 239000002131 composite material Substances 0.000 title claims abstract description 29
- 239000011573 trace mineral Substances 0.000 title claims abstract description 16
- 235000013619 trace mineral Nutrition 0.000 title claims abstract description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 15
- 235000010755 mineral Nutrition 0.000 title claims abstract description 15
- 239000011707 mineral Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 33
- 239000002184 metal Substances 0.000 claims abstract description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000002366 mineral element Substances 0.000 claims abstract description 14
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052742 iron Inorganic materials 0.000 claims abstract description 12
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 11
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 11
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 11
- 239000001168 astaxanthin Substances 0.000 claims abstract description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 10
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 10
- 229960005375 lutein Drugs 0.000 claims abstract description 9
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 9
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 9
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011777 magnesium Substances 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- 239000011591 potassium Substances 0.000 claims abstract description 8
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 8
- 239000011701 zinc Substances 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000011575 calcium Substances 0.000 claims abstract description 7
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 7
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 5
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 5
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 5
- 229910052802 copper Inorganic materials 0.000 claims abstract description 5
- 239000010949 copper Substances 0.000 claims abstract description 5
- 235000012661 lycopene Nutrition 0.000 claims abstract description 5
- 239000001751 lycopene Substances 0.000 claims abstract description 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 5
- 229960004999 lycopene Drugs 0.000 claims abstract description 5
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract description 5
- 229940106796 pycnogenol Drugs 0.000 claims abstract description 5
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 4
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- 235000008210 xanthophylls Nutrition 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 33
- 238000003756 stirring Methods 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 18
- 235000010208 anthocyanin Nutrition 0.000 claims description 17
- 229930002877 anthocyanin Natural products 0.000 claims description 17
- 239000004410 anthocyanin Substances 0.000 claims description 17
- 150000004636 anthocyanins Chemical class 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 229940104261 taurate Drugs 0.000 claims description 10
- 239000013256 coordination polymer Substances 0.000 claims description 8
- 229920001795 coordination polymer Polymers 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 235000013402 health food Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000012680 lutein Nutrition 0.000 claims description 5
- 239000001656 lutein Substances 0.000 claims description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 150000001453 anthocyanidins Chemical class 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000003760 magnetic stirring Methods 0.000 claims description 3
- 238000010907 mechanical stirring Methods 0.000 claims description 3
- 229910001453 nickel ion Inorganic materials 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 4
- 150000001452 anthocyanidin derivatives Chemical class 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 14
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 13
- 229910021645 metal ion Inorganic materials 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 8
- 229940090949 docosahexaenoic acid Drugs 0.000 description 7
- -1 iron ions Chemical class 0.000 description 6
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 4
- 229910001431 copper ion Inorganic materials 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- YZURQOBSFRVSEB-UHFFFAOYSA-L magnesium;2-aminoethanesulfonate Chemical compound [Mg+2].NCCS([O-])(=O)=O.NCCS([O-])(=O)=O YZURQOBSFRVSEB-UHFFFAOYSA-L 0.000 description 4
- 125000004430 oxygen atom Chemical group O* 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000010668 complexation reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910001437 manganese ion Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- OPSXJNAGCGVGOG-DKWTVANSSA-L Calcium L-aspartate Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CC([O-])=O OPSXJNAGCGVGOG-DKWTVANSSA-L 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000020803 food preference Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical group O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a mineral trace element and taurine composite product, a preparation method and application, wherein the composite product is a complex obtained by fully reacting 10 parts of taurine, 7-21 parts of metal mineral elements and 0.5-5 parts of supplementary materials in parts by mole; the metal mineral element is one, two or more of sodium, copper, manganese, nickel, potassium, magnesium, iron, zinc and calcium; the supplementary material is one, two or more of anthocyanidin, xanthophyll, astaxanthin, vitamin C, microorganism E, coenzyme Q10, SOD, pycnogenol, lycopene and DHA. The product of the invention contains taurine and microelements required by human body, the preparation method is simple, the raw materials are cheap, and the obtained product has high purity and excellent quality.
Description
Technical Field
The invention relates to the technical field of food additives, in particular to a mineral trace element and taurine composite product, a preparation method and application.
Background
Taurine is a beta-sulphenyl amino acid widely distributed in animal tissue cells, and is an important substance for regulating normal physiological functions of organisms. Taurine not only plays an important role in the development of the brain, ovary, heart, liver, nervous system and other organisms of human bodies, but also has a plurality of physiological functions of resisting tumor, enhancing immunity, protecting heart, reducing blood pressure, reducing blood fat and blood sugar, relieving fatty liver, reducing transaminase, resisting aging and the like.
The human body trace elements mainly comprise iron, copper, manganese, zinc, cobalt, nickel, vanadium, fluorine, selenium, iodine, silicon, tin and the like. The weight of each element in the human body is between 0.01 and 0.005 percent. The microelements have important effects on maintaining metabolism, body function and immunity of human body. The trace elements are usually ingested by food, and if the diet is improperly prepared, food preference or certain diseases are suffered, deficiency is easily caused, and a series of body diseases are caused.
Most of the existing mineral trace element products are varieties with single components, such as taurine magnesium tablets, aspartic acid calcium effervescent tablets and the like, the components are single, and multiple products are usually needed to be matched for use in use, so that the administration is inconvenient. And generally the production process is complicated and requires expensive raw materials.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a mineral trace element and taurine composite product with simple production process, high product purity and excellent quality, a preparation method and application.
The technical scheme adopted by the invention is as follows:
a mineral trace element and taurine composite product is a complex obtained by fully reacting 10 parts of taurine, 7-21 parts of metal mineral elements and 0.5-5 parts of supplementary materials in parts by mole;
the metal mineral element is one, two or more of sodium, copper, manganese, nickel, potassium, magnesium, iron, zinc and calcium;
the supplementary material is one, two or more of anthocyanidin, xanthophyll, astaxanthin, vitamin C, microorganism E, coenzyme Q10, SOD, pycnogenol, lycopene and DHA.
Further, the metal mineral elements comprise the following components in parts by mole: 1-3 parts of manganese, 1-3 parts of nickel ions, 1-3 parts of potassium, 1-3 parts of magnesium, 1-3 parts of iron, 1-3 parts of zinc and 1-3 parts of calcium.
Further, the supplementary materials comprise the following components in parts by mole: 0.1-1 part of anthocyanin, 0.1-1 part of lutein, 0.1-1 part of astaxanthin, 0.1-1 part of vitamin E and 0.1-1 part of DHA.
A preparation method of a mineral trace element and taurine composite product comprises the following steps:
step 1: dissolving taurine in an aqueous solution to obtain a taurine solution;
step 2: adding metal salt corresponding to the metal mineral element into the taurine solution obtained in the step 1, and fully mixing; fully reacting at 50-200 ℃;
and step 3: removing volatile substances from the reaction product in the step 2 to obtain the taurate coordination polymer;
and 4, step 4: and (3) adding a supplementary material into the taurate coordination polymer obtained in the step (3), fully reacting, cleaning and drying to obtain the required composite product.
Further, the mixing in the step 2 is performed by adopting a stirring method, and the stirring method is one of mechanical stirring, magnetic stirring, manual stirring, ultrasonic stirring and vibration stirring; step 4, stirring and reacting at 50 ℃. .
Further, the reaction time in the step 2 is 3-10 hours, and the reaction time in the step 4 is 1 hour.
Further, in the step 2, the heating is performed to a required temperature by one of heating rod heating, infrared heating and high-frequency electromagnetic heating.
Further, the mass concentration of taurine in the taurine acid solution in the step 1 is 5 wt.% to 50 wt.%.
Use of a composite product as an additive to a food or health food.
Further, the food or health food comprises one of a vitamin complex, a beverage and a dairy product.
The invention has the beneficial effects that:
(1) the composite product obtained by the invention can be rapidly dissociated in the acidic environment of gastric acid, the release amount of metal ions is promoted, and the absorption of inorganic salt by stomach is improved;
(2) the metal sulfonate is a porous soft structure with adsorption and catalysis properties, and is favorable for better combination of the metal sulfonate and other substances;
(3) the manganese ions, the iron ions and the copper ions can have a synergistic effect with other metal ions, so that the rapid generation of the metal sulfonate and the complex polymer thereof can be accelerated, and the reaction yield is increased;
(4) the supplements such as anthocyanin and the like in the invention have complexation with metal ions, and can present different colors, thereby being convenient for identification and distinction;
(5) the product of the invention contains taurine and microelements required by human body, the preparation method is simple, the raw materials are cheap, and the obtained product has high purity and excellent quality.
Detailed Description
The present invention is further illustrated by the following specific examples.
A mineral trace element and taurine composite product is a complex obtained by fully reacting 10 parts of taurine, 7-21 parts of metal mineral elements and 0.5-5 parts of supplementary materials in parts by mole;
the metal mineral element is one, two or more of sodium, copper, manganese, nickel, potassium, magnesium, iron, zinc and calcium; preferably, the metal mineral elements comprise the following components in parts by mole: 1-3 parts of manganese, 1-3 parts of nickel ions, 1-3 parts of potassium, 1-3 parts of magnesium, 1-3 parts of iron, 1-3 parts of zinc and 1-3 parts of calcium.
The supplementary material is one, two or more of anthocyanidin, xanthophyll, astaxanthin, vitamin C, microorganism E, coenzyme Q10, SOD, pycnogenol, lycopene and DHA. Preferably, the supplementary materials comprise the following components in parts by mole: 0.1-1 part of anthocyanin, 0.1-1 part of lutein, 0.1-1 part of astaxanthin, 0.1-1 part of vitamin E and 0.1-1 part of DHA.
A preparation method of a mineral trace element and taurine composite product comprises the following steps:
step 1: dissolving taurine in an aqueous solution to obtain a taurine solution, and placing the taurine solution in a reaction container; the mass concentration of the taurine in the taurine acid solution is 5 wt.% to 50 wt.%.
Step 2: adding metal salt corresponding to the metal mineral element into the taurine solution obtained in the step 1, and fully mixing; fully reacting at 50-200 ℃; the mixing is carried out by adopting a stirring method, and the stirring method is one of mechanical stirring, magnetic stirring, manual stirring, ultrasonic stirring and vibration stirring; the reaction time is 3-10 h. Heating to a required temperature by one of heating rod heating, infrared heating and high-frequency electromagnetic heating.
And step 3: removing volatile substances from the reaction product in the step 2 to obtain the taurate coordination polymer; volatile materials were removed by a reduced pressure distillation system.
And 4, step 4: and (3) adding a supplement into the taurate coordination polymer obtained in the step (3), stirring and reacting at 50 ℃, cleaning and drying to obtain the required composite product, wherein the reaction time is 1 h.
The composite product is used as additive for food or health food. The food or health food comprises one of compound vitamins, beverage, and milk product (such as cow milk, sheep milk, milk powder, yogurt, etc.); it can also be added into other food.
The taurine in the invention can be directly used as a ligand, and the ligand contains an amino nitrogen atom and a sulfooxy atom which can coordinate with different metal ions. In addition, the coordination mode of the sulfonate is various, and the sulfonate can be monodentate (namely, single oxygen atom is used for independent coordination), and can also be bidentate, tridentate, bridged (namely, two oxygen atoms or three oxygen atoms in the sulfonate are used for coordination) or chelate coordination (namely, nitrogen and one oxygen atom of the sulfonate are used for coordination with metal to form a chelate six-membered ring). The metal sulfonate has a porous soft structure with adsorption and catalysis properties, and the structure is favorable for better combination of the metal sulfonate and other substances and development and production of products. (for example, taurine binary polymer, crystal containing metal Ni ion and K ion, which form three-dimensional supermolecular framework structure through weak coordination and abundant hydrogen bond)
Manganese ions, iron ions and copper ions with catalytic properties have synergistic effect with other ions, can accelerate the rapid generation of metal sulfonate and a complex polymer thereof, and increase the reaction yield. At present, one of the most important means for resisting aging and diseases of human beings is antioxidation, and anthocyanin, lutein, astaxanthin, vitamin C, vitamin E, coenzyme Q10, SOD, pycnogenol, lycopene and the like have the antioxidation function. DHA (Docosahexaenoic acid), also known as brain gold, is a polyunsaturated fatty acid of the docosahexaenoic acid Omega-3 series. It has the important effects of promoting the development of visual acuity, improving the sleep quality of infants, improving immunity, resisting inflammation, improving memory problems of old people and other chronic health problems, enhancing the development of skeletal muscles, strengthening body, resisting cancers and the like.
The organic component and the inorganic component are combined to have mutual synergistic effect. For example, anthocyanin and astaxanthin can form a metal complex with metal ions, the molecular structure of anthocyanin contains a large amount of phenolic hydroxyl and substituent groups (such as methoxy), so that the chemical property of anthocyanin is more active, and the structure and color of anthocyanin can be changed due to the complexation of anthocyanin and metal ions, so that the color of composite medicine can be effectively adjusted, and the composite medicine can be used for medicine identification, differentiation and the like. After the anthocyanin and the metal element are subjected to a coordination reaction, the electronic configuration in the whole molecule is changed, so that hydrogen on the hydroxyl is unstable, and the anthocyanin has stronger oxidation resistance. The metal elements and hydroxyl groups at the ortho positions of the B ring in the anthocyanin molecule form stable five-membered rings, so that electron cloud distribution of the whole molecule is delocalized, and the lotus procyanidin forms a relatively stable free radical intermediate. The more stable this phenoxy radical, the more active the anthocyanin metal complex is at scavenging free radicals.
Examples
A preparation method of a mineral trace element and taurine composite product comprises the following steps:
step 1: dissolving 3mol of taurine in an aqueous solution to prepare a taurine solution with the taurine concentration of 50 wt.%, and placing the taurine solution in a reaction container.
Step 2: adding 1mol of MgCl into the taurine solution obtained in the step 12Heating to 70 ℃ in a reaction vessel, and preserving heat for 10h to generate magnesium taurate solution; then 1mol of K is added to the solution2CO3The weak alkaline solution reacts for 1 hour, and part of magnesium taurate generates magnesium taurate complexes due to the alkaline environment.
Then continuously adding 1mol of nickel acetate solution and 1MnCl with catalytic activity through a peristaltic pump2And mechanically stirring, heating to 150 ℃ by adopting high-frequency electromagnetic heating, and continuously preserving heat for 10 hours.
And step 3: and (3) obtaining the taurate coordination polymer by using the volatile substances of the reaction product in the step (2). Catalytically active MnCl2The coordination compound can be rapidly dissociated in the environment of gastric acid, promotes the release amount of metal and improves the absorption of inorganic salt by stomach.
And 4, step 4: cooling to 50 ℃, adding supplementary materials anthocyanin, lutein, astaxanthin and vitamin E into the taurate coordination polymer obtained in the step 3, and reacting for 1 h; after the reaction is full, volatilizing part of H by a reduced pressure distillation system2O, HCl, the metal ions which do not generate the complexes and the residual taurine generate a composite product of manganese taurate, nickel taurine, magnesium taurate and potassium taurine and a metal complex of anthocyanin and astaxanthin. And adding dry ice into the mixed solution, quickly cooling to normal temperature, and performing vacuum pumping, freezing and low-temperature drying to obtain the required composite product.
Taurine and metal salts produce taurates having the structure shown in the following table:
TABLE 1 chemical structural formula of taurate
The composite product obtained by the invention can be rapidly dissociated in the acidic environment of gastric acid, the release amount of metal ions is promoted, and the absorption of inorganic salt by stomach is improved; the metal sulfonate is a porous soft structure with adsorption and catalysis properties, and is favorable for better combination of the metal sulfonate and other substances; manganese ions, iron ions and copper ions can have a synergistic effect with other metal ions, so that the rapid generation of metal sulfonate and a complex polymer thereof can be accelerated, and the reaction yield is increased; it is common to have one of the manganese, iron, copper ions together, followed by the other metal ions listed above. The metal salt is usually a chloride salt, a carbonate salt or a carboxylate salt.
In the invention, the supplementary materials such as anthocyanin and the like and metal ions are subjected to complexation, and can present different colors, thereby being convenient for identification and distinction; the product contains taurine and trace elements required by human body, the preparation method is simple, the raw materials are cheap, and the obtained product has high purity and excellent quality.
Claims (10)
1. A mineral trace element and taurine composite product is characterized in that the composite product is a complex obtained by fully reacting 10 parts of taurine, 7-21 parts of metal mineral elements and 0.5-5 parts of supplementary materials in parts by mole;
the metal mineral element is one, two or more of sodium, copper, manganese, nickel, potassium, magnesium, iron, zinc and calcium;
the supplementary material is one, two or more of anthocyanidin, xanthophyll, astaxanthin, vitamin C, microorganism E, coenzyme Q10, SOD, pycnogenol, lycopene and DHA.
2. The mineral microelement and taurine composite product according to claim 1, wherein the metal mineral elements comprise, in terms of mole fraction: 1-3 parts of manganese, 1-3 parts of nickel ions, 1-3 parts of potassium, 1-3 parts of magnesium, 1-3 parts of iron, 1-3 parts of zinc and 1-3 parts of calcium.
3. The mineral microelement and taurine composite product according to claim 1, wherein the supplementary material comprises, in terms of mole parts: 0.1-1 part of anthocyanin, 0.1-1 part of lutein, 0.1-1 part of astaxanthin, 0.1-1 part of vitamin E and 0.1-1 part of DHA.
4. The method for preparing the composite product of mineral trace elements and taurine as claimed in any one of claims 1 to 3, comprising the steps of:
step 1: dissolving taurine in an aqueous solution to obtain a taurine solution;
step 2: adding metal salt corresponding to the metal mineral element into the taurine solution obtained in the step 1, and fully mixing; fully reacting at 50-200 ℃;
and step 3: removing volatile substances from the reaction product in the step 2 to obtain the taurate coordination polymer;
and 4, step 4: and (3) adding a supplementary material into the taurate coordination polymer obtained in the step (3), fully reacting, cleaning and drying to obtain the required composite product.
5. The preparation method according to claim 4, wherein the mixing in the step 2 is performed by a stirring method, and the stirring method is one of mechanical stirring, magnetic stirring, manual stirring, ultrasonic stirring and vibration stirring; step 4, stirring and reacting at 50 ℃.
6. The preparation method according to claim 4, wherein the reaction time in the step 2 is 3-10 h, and the reaction time in the step 4 is 1 h.
7. The method according to claim 4, wherein the heating to a desired temperature in step 2 is performed by one of heating with a heating rod, infrared heating, and high-frequency electromagnetic heating.
8. The method according to claim 4, wherein the mass concentration of taurine in the taurine acid solution in the step 1 is 5 wt.% to 50 wt.%.
9. Use of a composite product obtained by the method according to claims 4 to 8, wherein the composite product is used as an additive for food or health food.
10. The use of claim 9, wherein the food or health food comprises one of a vitamin complex, a beverage, and a dairy product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111614703.XA CN114223908A (en) | 2021-12-27 | 2021-12-27 | Mineral trace element and taurine composite product, preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111614703.XA CN114223908A (en) | 2021-12-27 | 2021-12-27 | Mineral trace element and taurine composite product, preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114223908A true CN114223908A (en) | 2022-03-25 |
Family
ID=80763538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111614703.XA Pending CN114223908A (en) | 2021-12-27 | 2021-12-27 | Mineral trace element and taurine composite product, preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114223908A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1343660A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its synthesizing process |
CN1343657A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its preparing process |
CN1343659A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its synthesizing process |
CN1343658A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion compound and its synthesizing process |
CN1343656A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its preparing process |
CN1390540A (en) * | 2001-06-07 | 2003-01-15 | 李卫平 | Preparing process and usage of zine taurinate |
CN101631836A (en) * | 2007-03-12 | 2010-01-20 | 国立大学法人香川大学 | Method for production of purified anthocyanin |
CN112206237A (en) * | 2019-07-10 | 2021-01-12 | 杨维稼 | Anti-aging composition containing zinc taurate, preparation method and application thereof |
CN113788871A (en) * | 2021-08-19 | 2021-12-14 | 南方医科大学 | Coordination compound and preparation method and application thereof |
-
2021
- 2021-12-27 CN CN202111614703.XA patent/CN114223908A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1343660A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its synthesizing process |
CN1343657A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its preparing process |
CN1343659A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its synthesizing process |
CN1343658A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion compound and its synthesizing process |
CN1343656A (en) * | 2001-05-16 | 2002-04-10 | 广西半宙制药(集团)有限责任公司 | Taurine-metal ion match and its preparing process |
CN1390540A (en) * | 2001-06-07 | 2003-01-15 | 李卫平 | Preparing process and usage of zine taurinate |
CN101631836A (en) * | 2007-03-12 | 2010-01-20 | 国立大学法人香川大学 | Method for production of purified anthocyanin |
US20100041877A1 (en) * | 2007-03-12 | 2010-02-18 | National University Corporation Kagawa Univesity | Method for producing purified anthocyanin |
CN112206237A (en) * | 2019-07-10 | 2021-01-12 | 杨维稼 | Anti-aging composition containing zinc taurate, preparation method and application thereof |
CN113788871A (en) * | 2021-08-19 | 2021-12-14 | 南方医科大学 | Coordination compound and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
李琴等: ""莲原花青素与金属离子相互作用对抗氧化的影响"", 《中国食品学报》 * |
蔡金华: ""牛磺酸金属配合物的合成及晶体结构研究"", 《中国优秀博硕士学位论文全文数据库(硕士) 工程科技Ⅰ辑》 * |
郭思杙等: ""金属离子对紫甘蓝花青素颜色稳定性的影响"", 《中国调味品》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6114379A (en) | Bioavailable chelates of creatine and essential metals | |
CA2628162C (en) | Salts of mineral nutrients stabilized with amino acids and/or ammonium salt, products and food supplement that contain them and procedures of obtention | |
CN102711731B (en) | Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition | |
CN101352255A (en) | Medlar nutrient effervescence decoction pieces and process for producing the same | |
CN104068300A (en) | Astaxanthin jellies and preparation process thereof | |
CN104738777A (en) | Honey-wolfberry-tomato juice and preparation method thereof | |
CN113208104A (en) | Formula and preparation method of antioxidant full-nutrition powder | |
CN117859892A (en) | Gel-like full-nutrition special medical food formula based on animal and plant double proteins and preparation method thereof | |
JP2006509012A (en) | Dimetal hydroxymalate | |
CN114223908A (en) | Mineral trace element and taurine composite product, preparation method and application | |
CN104757640A (en) | Lemon honey juice and processing method thereof | |
CN100558257C (en) | A kind of spray drying process of water-soluble iron chelate of glycine | |
CN105777534B (en) | Calcium citrate salts and preparation method thereof and purposes | |
CN116250634A (en) | Selenium-enriched prebiotic AD high-calcium protein powder solid beverage | |
CN101455337A (en) | Balsam pear nutrient effervescence tablet and manufacture method thereof | |
CN107647235A (en) | A kind of vitaminAD solid beverage and preparation method thereof | |
CN106360626A (en) | Preparation method of organic nutrient low-sodium salt for children | |
CN113841795A (en) | Self-assembled small peptide chelated copper feed additive and preparation method thereof | |
CN102726532A (en) | Kiwi fruit vegetable goat milk enabling long-term storage under normal-temperature condition and preparation method thereof | |
CN107125752B (en) | Phosphatidylserine oral liquid for improving memory function and preparation method thereof | |
CN106260816A (en) | A kind of sugar-free Passifolra edulis fruit jam and preparation method thereof | |
CN111493257A (en) | Protein solid beverage and preparation method thereof | |
CN106306159A (en) | Fruit acid thick tea soup rich in vitamins | |
RU2778509C1 (en) | Method for obtaining a highly digestible element-balanced polycomponent preparation based on colloidal chelate complexes of essential trace elements of zinc, manganese, iron, copper and cobalt | |
EP1103259A1 (en) | Use of y-butyrobetaine salts for the preparation of compositions suitable for human or animal nutrition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |